The Pharmaceutical Research & Manufacturers of America (PhRMA) has as its mission to conduct effective advocacy for public policies that encourage discovery of important new medicines for patients by pharmaceutical and biotechnology research companies. To accomplish this mission, PhRMA is dedicated to achieving these goals in Washington, the states and the world:
Broad patient access to safe and effective medicines through a free market, without price controls;
Strong intellectual property incentives;
And transparent, effective regulation and a free flow of information to patients.
Who We Are:
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents innovative biopharmaceutical research and discovery companies. PhRMA is devoted to advancing public policies in the U.S. and around the world that support innovative medical research, yield progress for patients today and provide hope for the treatments and cures of tomorrow.
Key Facts about the Biopharmaceutical Industry:
– Since 2000, PhRMA member companies have invested more than $900 billion in the search for new treatments and cures.
– America’s biopharmaceutical industry is the global leader in medical innovation, with more than 500 new medicines approved by the Food and Drug Administration since 2000.
– The biopharmaceutical pipeline has over 7,000 new medicines currently in development around the world.
Get fresh content daily by subscribing to our updates at https://catalyst.phrma.org/subscribe
policy, scientific research, advocacy, public affairs, federal affairs, state government affairs, pharmaceuticals